Your browser doesn't support javascript.
loading
Mycobacterium shinjukuense infection successfully treated with clarithromycin, rifampicin, and ethambutol.
Nakamura, Kayo; Murakami, Etsuko; Kishino, Daizo; Mashimo, Shuko; Kurioka, Yusuke; Shibata, Yusaku; Taniguchi, Arihiko; Higo, Hisao; Hiramatsu, Yasushi; Maeda, Yoshinobu; Miyahara, Nobuaki.
Afiliación
  • Nakamura K; Department of Medicine, Japanese Red Cross Society Himeji Hospital, Japan.
  • Murakami E; Department of Medicine, Japanese Red Cross Society Himeji Hospital, Japan.
  • Kishino D; Department of Medicine, Japanese Red Cross Society Himeji Hospital, Japan.
  • Mashimo S; Department of Medicine, Japanese Red Cross Society Himeji Hospital, Japan.
  • Kurioka Y; Department of Medicine, Japanese Red Cross Society Himeji Hospital, Japan.
  • Shibata Y; Department of Medicine, Japanese Red Cross Society Himeji Hospital, Japan.
  • Taniguchi A; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan.
  • Higo H; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Hiramatsu Y; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan.
  • Maeda Y; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Miyahara N; Department of Medicine, Japanese Red Cross Society Himeji Hospital, Japan.
Respir Med Case Rep ; 45: 101894, 2023.
Article en En | MEDLINE | ID: mdl-37485238
ABSTRACT
We present the case of a 59-year-old woman diagnosed with Mycobacterium shinjukuense infection using mass spectrometry of bronchioalveolar lavage fluid. We initiated treatment with clarithromycin, rifampicin, and ethambutol based on the results of drug susceptibility testing, which improved lung opacities. Most previous cases were treated with the standard regimen for Mycobacterium tuberculosis. However, our regimen may provide a therapeutic option for this rare nontuberculous Mycobacterium infection.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_tuberculosis Idioma: En Revista: Respir Med Case Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_tuberculosis Idioma: En Revista: Respir Med Case Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón